Stay updated on Nintedanib for Progressive Fibrosing ILD Clinical Trial
Sign up to get notified when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.

Latest updates to the Nintedanib for Progressive Fibrosing ILD Clinical Trial page
- Check6 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added. The prior government funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded a site-wide government funding notice and updated the revision tag to v3.4.1, replacing the previous v3.4.0 revision.SummaryDifference0.2%

- Check48 days agoChange DetectedShow glossary added; metadata updates include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0, while the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedLocations section updated to include a broader list of study sites across the United States and Canada, and a revision tag v3.3.3.SummaryDifference1%

- Check106 days agoChange DetectedRevision updated to v3.3.2. The previous revision v3.3.1 has been removed.SummaryDifference0.0%

Stay in the know with updates to Nintedanib for Progressive Fibrosing ILD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.